The KCTD13 gene helps cells clear away certain proteins and plays an important role in early brain development. If it does not work as expected, brain growth and nerve cell signaling can be altered, which may contribute to developmental delay, learning or behavior differences, and changes in head size in some people. Many clinicians pay attention to this gene when they interpret findings in the 16p11.2 chromosome region, which is linked to a range of neurodevelopmental features.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some provide the directions for producing proteins, which are the working parts of cells. Others mainly control when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
KCTD13Gene function
What if the gene works
The KCTD13 gene helps brain cells grow and connect in a balanced way during development. Its protein also helps control how certain other proteins are cleared away inside cells.
Risk
What if the gene does not work
Milder to more severe variants in the KCTD13 gene can reduce how well cells regulate protein turnover through the CUL3 pathway. This may alter cell signaling and growth, with impact varying by how much gene activity changes.
Treatment
What does that mean for your treatment
For people with a pathogenic or loss-of-function variant in the KCTD13 gene, no treatment or drug choice based specifically on the KCTD13 gene is currently established. The KCTD13 gene is being studied as part of a chromosome 16 region linked to brain development, but this has not yet changed routine medical management.
Gene function
What if the gene works
In many tissues, the KCTD13 gene helps cells keep certain proteins at the right level. That steady control supports normal cell shape, signaling, and growth. It is especially relevant during early brain development, when timing and balance matter.
The KCTD13 gene helps cells label selected proteins so they can be broken down when they are no longer needed. This keeps protein levels balanced and supports smooth day to day cell activity.
Through this protein labeling system, the KCTD13 gene helps regulate RHOA, a protein that guides cell shape, movement, and internal structure. This supports orderly growth and helps cells respond in a controlled way to routine signals.
During early development, the KCTD13 gene is active in the nervous system, where careful protein control supports the growth and arrangement of developing brain cells. This helps explain how the KCTD13 gene works in cells during brain development.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These changes are common and are part of normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply reflect natural genetic variation. In some cases, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Understanding how variants influence the KCTD13 gene's function starts at the protein level: some changes alter the protein's shape or stability, so it may not bind its partner proteins well or help control how selected proteins are cleared inside cells. Milder variants may leave some activity in place, while more disruptive variants can shorten the protein, make it unstable, or stop it from being made at all. This creates a spectrum of reduced cellular effect rather than one single outcome.
How variants are linked to conditions
The KCTD13 gene does not yet have a broadly confirmed link to a specific health condition, though this may change as research develops. Interest in KCTD13 gene variants and related conditions mainly comes from studies of larger chromosome changes rather than a single, clearly defined KCTD13-related diagnosis. Anyone with a confirmed KCTD13 variant should rely on guidance from their doctor or genetic counselor rather than general information.
A variant is not necessarily a diagnosis
Genetic variants are common and are a normal feature of human biology. Most do not directly affect health and simply reflect natural differences among people. For many genes, having a variant associated with a condition suggests a possible link rather than a certain diagnosis, particularly when more than one gene and environmental influences play a role. In some situations, though, one well understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risks related to KCTD13 itself. For many living with a KCTD13-related finding, overall risk can also depend on the exact genetic change and whether other genes are involved. Anyone with concerns about personal or family risk should speak with a doctor or genetic counselor.
Inheritance of KCTD13 variants
There is not yet a broadly confirmed Mendelian pattern that clearly explains how KCTD13 gene variants are inherited for a specific KCTD13 related condition, and this picture may become clearer as research grows. In practical terms, questions about how KCTD13 gene variants are inherited do not yet have one established answer such as autosomal dominant or autosomal recessive. The KCTD13 gene is located on chromosome 16, which is an autosome, so each person inherits one copy from each parent.
What does my KCTD13 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific condition for KCTD13 on its own, and most of what is known comes from ongoing research. If you have a KCTD13 result and want to understand what it could mean for relatives, a doctor or genetic counselor can explain it in the context of your exact finding and family history.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for the KCTD13 gene usually uses a blood or saliva sample to look for DNA variants. Depending on the test, the lab may read the gene’s sequence directly or check for missing or extra pieces of DNA as part of a broader gene panel or chromosome study.
When should I consider getting a genetic test?
There isn’t yet a broadly established, KCTD13-specific reason to get genetic testing in routine care. Testing decisions are usually based on symptoms, development, and family history, together with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains varies based on the condition and the type of variant involved. Lifestyle, environment, age, and medical history, along with many other influences, affect how the body works over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, these results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same medication may work well for one person, work less well for another, or cause more side effects in someone else. Differences in how the body absorbs, breaks down, transports, or responds to a drug are common, and they can influence both treatment benefit and sensitivity to a medicine.
What is Pharmacogenetics?
Pharmacogenetics explores how differences in genes can shape the way a person responds to medications. It examines links between genes and drugs to help explain why the same treatment may affect people differently. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support treatment decisions that are more informed and more individualized. To learn more about this topic, visit the LearnHub.
Drugs influenced by the KCTD13 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how medicines work, so routine prescribing is not based on it. Questions about side effects, new symptoms, or how your medicines may affect you are best discussed with your doctor or pharmacist.
History
KCTD13 entered genetics research through work on chromosome 16p11.2, a region linked to differences in development and behavior. In the early 2010s, scientists narrowed attention to the KCTD13 gene as one of several genes that might help explain why this chromosome region drew so much interest. From these first observations, research expanded steadily as animal studies and human genetic studies explored its possible contribution within the larger 16p11.2 segment. Over time, scientists’ understanding of the KCTD13 gene has changed, with growing recognition that it is one piece of a broader genetic picture rather than a standalone explanation. Its history is mainly tied to this wider effort to understand how grouped gene changes on chromosome 16 can shape health and development.